Do differences in dialysis prescription impact on KDOQI bone mineral targets? the pan thames renal audit

Blood Purification

Volumn 30, Issue 2, 2010, Pages 111-117

  Davenport, Andrew ^a   Gardner, Carrie ^b   Delaney, Michael ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Audit Commission   (United Kingdom)

^c EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Calcium; Clinical targets; Haemodialysis; Kidney Disease Outcomes Quality Initiative; Parathyroid hormone; Phosphate

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BONE MINERAL; CLINICAL PRACTICE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSATE; DIALYSIS; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS; HUMAN; KIDNEY DISEASE; KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

AGED; BONE AND BONES; CALCIUM; DIALYSIS SOLUTIONS; FEMALE; HEMODIAFILTRATION; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHATES; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77955539562     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319954     Document Type: Article

References (22)

1. Sugisaki H, Onohara M, Kunitomo T: Dy-namic behaviour of plasma phosphate in chronic dialysis patients. Trans Am Soc Artif Intern Organs 1982; 28: 302-307.
2. National Kidney Foundation: KDOQI clini-cal practice guidelines for bone metabolism and disease in chronic kidney disease. 2003. www.kidney.org/ professionals/kdoqi/ guidelines-bone/index.htm.
3. Renal Association: Clinical practice guide-lines, ed 4. Module 2: complications. 2007. www.renal.org/guidelines.
4. Davenport A, Goel S, Mackenzie JC: Audit of the use of calcium carbonate as a phosphate binder in 100 patients treated with continu-ous ambulatory peritoneal dialysis (CAPD). Nephrol Dial Transplant 1992; 7: 632-635.
5. Block GA, Hulbert-Shearon TE, Levin NW, Port FK: Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic haemodialysis pa-tients: a national study. Am J Kidney Dis 1998; 31: 607-617.
6. Kalpakan MA, Mehrotra R: Vascular calcifi-cation and disordered mineral metabolism in dialysis patients. Semin Dial 2007; 20: 139-143.
7. Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K, Miskulin D, Meyer KB, Bedrick EJ, Johnson HK, Zager PG: Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organisation. J Am Soc Nephrol 2007; 18: 2377-2384.
8. UK Renal Registry: Biochemistry profile of patients receiving dialysis in the UK in 2007: national and centre specific analyses. Chapter 10. 2008. www.renalreg.com/reports/renal-registry-reports/2008/-.
9. Wald R, Tentori F, Tighiouart MS, Zager PG, Miskulin DC: Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) clini-cal practice guidelines for bone metabolism and disease in a large dialysis network. Am J Kidney Dis 2007; 49: 257-266.
10. Morey B, Walker R, Davenport A: More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in endstage kidney failure haemodialysis patients. Nephron Clin Pract 2008; 109:c173-c180.
11. Lindsay M, Pierratos A, Lockridge RS: Calcium and phosphate control. Contrib Nephrol 2004; 145: 63-68.
12. Arenas MD, Alvarez-Ude F, Gil MT, Moledous A, Malek T, Nunez C, Devesa R, Carreton MA, Soriano A: Application of NKF-K/DOQI clinical practice guidelines for bone metabolism and disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units. Nephrol Dial Transplant 2006; 21: 1663-1668.
13. Davenport A: Replacement and dialysate fluids for patients with acute renal failure treated by continuous venovenous hemofiltration and/or hemodiafiltration. Contrib Nephrol 2004; 144: 317-328.
14. Al-Kejaili F, Kortas C, Leitch R, Heidenheim AP, Clement L, Nesrallah G, Lindsay RM: Nocturnal but not short hours quotidian haemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14: 2322-2328.
15. Vaslaki L, Major L, Berta K, Kararson A, Misz M, Pethoe F, Ladanyi E, Fodor B, Stein G, Pischetsrieder M, Zima T, Wojke R, Gau-ly A, Passlick-Deetjen J: On-line haemodia-filtration versus haemodialysis: stable he-matocrit with less erythropoietin and im-provement of other relevant blood param-eters. Blood Purif 2006; 24: 163-173.
16. Spalding EM, Chamney PW, Farrington K: Phosphate kinetics during haemodialysis: evidence for biphasic regulation. Kidney Int 2002; 61: 655-657.
17. Bolasco PG, Ghezzi PM, Ferrara R, Maxia M, Pinna M, Logias F, Cogoni G, Cadinu F, Ghisu T, Contu B, Casu D, Passaghe M, Pil-loni A, Gandu M, Gazzanelli L: Effect of on-line haemodiafiltration with endogenous re-infusion (HFR) on the calcium-phosphorus metabolism: medium term effects. Int J Artif Organs 2006; 29: 1042-1052.
18. Kidney Disease Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guidelines for the diagnosis, evaluation, prevention and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; 113:S1-S130.
19. Uhlig K Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, Sprague SM, Gold-farb S: KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the di-agnosis, evaluation, and treatment of CKD mineral and bone disorder (CKD-MBD). Am J Kidney Dis 2010; 55: 773-799.
20. Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn DC, Soroka SD, Chan C, Jindal K Klarenbach S: Canadian Society of Ne-phrology commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD mineral and bone disorder (CKD-MBD). Am J Kid-ney Dis 2010; 55: 800-812.
21. Udayaraj UP, Ben-Shlomo Y, Roderick P, Steenkamp R, Ansell D, Tomson CRV: Ethnicity, socioeconomic status, and attainment of clinical practice guidelines in dialysis patients in the United Kingdom. Clin J Am Soc Nephrol 2009; 4: 979-987.
22. Gotch F, Levin NW, Kotanko P: Calcium balance in dialysis is best managed by adjust-ing dialysate calcium guided by kinetic mod-eling of the interrelationship between calci-um intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif 2010; 29: 163-176.